AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, W. S
Right arrow Articles by Jones, P. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, W. S
Right arrow Articles by Jones, P. G
Agricola
Right arrow Articles by Harris, W. S
Right arrow Articles by Jones, P. G
American Journal of Clinical Nutrition, Vol. 86, No. 6, 1621-1625, December 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Comparison of the effects of fish and fish-oil capsules on the n–3 fatty acid content of blood cells and plasma phospholipids1,2,3

William S Harris, James V Pottala, Scott A Sands and Philip G Jones

1 From the Lipid and Diabetes Research Center, Saint Luke's Mid America Heart Institute, Kansas City, MO

Background: n–3 Fatty acids (FAs) have been shown to be beneficial for cardiovascular health. Whether n–3 FAs from oily fish consumed weekly or from fish-oil capsules taken daily are equally bioavailable is not clear.

Objective: The purpose of this study was to compare the rate and extent of enrichment of blood cell membranes [ie, red blood cells (RBCs)] and plasma phospholipids with n–3 FAs from these 2 sources.

Design: Healthy premenopausal female volunteers were randomly assigned to consume a daily average of 485 mg eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids either from 2 servings of oily fish (ie, salmon and albacore tuna) per week or from 1–2 capsules/d.

Results: After 16 wk, EPA+DHA in RBCs in the fish group (n = 11) increased from 4.0 ± 0.6% of total FAs to 6.2 ± 1.4%, whereas it rose from 4.3 ± 1.0% to 6.2 ± 1.4% in the capsule group (P < 0.0001 for both; NS for group effect). Similar results were observed in plasma phospholipids. EPA+DHA stabilized in the latter after 4 wk but continued to rise through week 16 in RBCs. EPA in RBCs increased significantly (P = 0.01) more rapidly in the fish group than in the capsule group during the first 4 wk, but rates did not differ significantly between groups thereafter. Total FA variances were less in RBCs than in plasma phospholipids (P = 0.04).

Conclusion: These findings suggest that the consumption of equal amounts of EPA and DHA from oily fish on a weekly basis or from fish-oil capsules on a daily basis is equally effective at enriching blood lipids with n–3 FAs.

Key Words: n–3 Fatty acids • eicosapentaenoic acid • docosahexaenoic acid • fish • fish oil • erythrocytes • phospholipids







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition